Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
28.83
0.00 (0.00%)
May 22, 2026, 4:00 PM EDT - Market closed

Immunocore Holdings Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-27.57-35.51-51.09-55.29-52.54-180.03
Depreciation & Amortization
2.563.274.24.095.347.59
Stock-Based Compensation
34.5137.734.1932.4732.8948.89
Other Adjustments
-18.99-6.86-10.210.04-10.722.4
Change in Receivables
-16.1-7.34-12.35-17.87-26.26-4.86
Changes in Accounts Payable
0.18-2.467.272.634.911.47
Changes in Accrued Expenses
18.5315.8971.539.0941.7610.68
Changes in Unearned Revenue
-0.34-0.39-0-8.01-25.5-29.07
Changes in Other Operating Activities
-33.65-15.01-17.47-4.2-19.07-0.18
Operating Cash Flow
-24.92-10.7126.062.94-49.21-143.11
Operating Cash Flow Growth
--786.43%---
Capital Expenditures
-5.82-4.34-5.17-5.43-2.2-1.39
Sale of Property, Plant & Equipment
--0.04-0.010.11
Purchases of Investments
-15-30-350---
Proceeds from Sale of Investments
1418----
Investing Cash Flow
-21.82-16.34-355.13-5.43-2.2-1.28
Long-Term Debt Issued
--402.5-50-
Long-Term Debt Repaid
---52.06--52-
Net Long-Term Debt Issued (Repaid)
--350.44--2-
Issuance of Common Stock
6.1912.376.834.35149.21288.19
Net Common Stock Issued (Repurchased)
6.1912.376.834.35149.21288.19
Other Financing Activities
---13.36--1.77-
Financing Cash Flow
10.4812.37343.8834.35145.44288.19
Effect of Exchange Rate Changes on Cash and Cash Equivalents
13.3726.66-1.718.29-12.650.63
Net Cash Flow
-37.54-14.6814.8131.8694.04143.8
Free Cash Flow
-30.75-15.0520.89-2.49-51.41-144.49
FCF Margin
-7.45%-3.76%6.73%-1.00%-152.68%-396.04%
Free Cash Flow Per Share
-0.60-0.300.42-0.05-1.12-3.40
Levered Free Cash Flow
-46.11-38.55355.98-38.33-49.31-190.92
Unlevered Free Cash Flow
-7.72-9.42-12.59-36.98-61.22-185.48
Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q